KP

Kedar Prasad Vaidya

Director Designated Partner DIN 08628364
DIN 08628364 First appointment Dec 2019 Primary industry Chemicals and Materials
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Kedar Prasad Vaidya

Data last updated:

Kedar Prasad Vaidya was a Designated Partner at Cellgene Biosciences Llp (2019–2020) and Designated Partner at Helix Biosciences Llp (from 2019). The companies operate in Chemicals and Materials.

DIN 08628364
Primary Designation Designated Partner
Industry Chemicals and Materials
First Appointment 03 Dec 2019
Oldest Company Age 6 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner03 Dec 20192019Under Process Of Striking Off
Designated Partner11 Dec 20192019Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Helix Biosciences Llp
Cellgene Biosciences Llp
Premium access

Shareholding and investment profile for Kedar Prasad Vaidya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kedar Prasad Vaidya

Kedar Prasad Vaidya was first appointed on 03 Dec 2019 as Designated Partner at Cellgene Biosciences Llp.

Kedar Prasad Vaidya held 2 earlier board appointments: Cellgene Biosciences Llp (Designated Partner, 03 Dec 2019 to 02 Sep 2020); Helix Biosciences Llp (Designated Partner, from 11 Dec 2019).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available